NMTC (STOCKS)
NeuroOne Medical Technologies Corporation Common Stock
$0.750700
+0.019000 (+2.60%)
Prev close: $0.731700
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- David A. Rosa
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $39.07M
- Employees
- 17
- P/E (TTM)
- -4.44
- P/B (TTM)
- 5.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q1)
|
$-0.03 | $-0.04 | +0.0108 | +26.47% |
|
Sep 2025 (Q4)
|
$-0.04 | $-0.04 | +0.0008 | +1.96% |
|
Jun 2025 (Q3)
|
$-0.03 | $-0.05 | +0.0210 | +41.18% |
|
Mar 2025 (Q2)
|
$-0.07 | $-0.09 | +0.0218 | +23.75% |
Financial Statements
| Revenues | $8.72M |
| Benefits Costs and Expenses | $15.54M |
| Cost Of Revenue | $3.93M |
| Costs And Expenses | $15.54M |
| Gross Profit | $4.78M |
| Operating Expenses | $12.43M |
| Selling, General, and Administrative Expenses | $7.23M |
| Depreciation and Amortization | $262.08K |
| Research and Development | $5.20M |
| Operating Income/Loss | -$7.64M |
| Income/Loss From Continuing Operations After Tax | -$6.83M |
| Income/Loss From Continuing Operations Before Tax | -$6.83M |
| Net Income/Loss | -$6.83M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$6.83M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.83M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.17 |
| Diluted Earnings Per Share | -$0.17 |
| Basic Average Shares | 133,350,379 |
| Diluted Average Shares | 133,350,379 |
| Assets | $8.58M |
| Current Assets | $8.07M |
| Inventory | $1.67M |
| Prepaid Expenses | $154.53K |
| Other Current Assets | $6.25M |
| Noncurrent Assets | $510.53K |
| Fixed Assets | $244.91K |
| Intangible Assets | $39.37K |
| Other Non-current Assets | $226.25K |
| Liabilities | $2.18M |
| Current Liabilities | $1.26M |
| Accounts Payable | $552.33K |
| Other Current Liabilities | $706.11K |
| Noncurrent Liabilities | $917.23K |
| Equity | $6.40M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.40M |
| Liabilities And Equity | $8.58M |
| Net Cash Flow From Operating Activities | -$6.16M |
| Net Cash Flow From Operating Activities, Continuing | -$6.16M |
| Net Cash Flow From Investing Activities | -$98.08K |
| Net Cash Flow From Investing Activities, Continuing | -$98.08K |
| Net Cash Flow From Financing Activities | $8.69M |
| Net Cash Flow From Financing Activities, Continuing | $8.69M |
| Net Cash Flow | $2.43M |
| Net Cash Flow, Continuing | $2.43M |
| Comprehensive Income/Loss | -$6.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$6.83M |
| Other Comprehensive Income/Loss | $0.00 |